Artelo Biosciences (ARTL) Assets (2014 - 2025)
Artelo Biosciences (ARTL) recorded Assets of $2.8 million in Q4 2025, down 40.4% from $4.7 million a year earlier and down 34.4% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Assets (2014 - 2025) Analysis & Trends
Starting with Q4 2014, Artelo Biosciences' Assets history includes 44 quarters.
- Annual Assets has declined for four straight years, with a five-year compound annual growth rate of -8.5% (FY2020 to FY2025).
- Across earlier years, Assets came in at $4.7 million in FY2024 (-64.0%), $13.04 million in FY2023 (-36.1%), $20.42 million in FY2022 (-27.7%) and $28.25 million in FY2021.
- The Q4 2025 figure is the lowest quarterly Assets since Q3 2019.
- On a year-over-year basis, Assets has declined for 12 consecutive quarters, with an average decline of 50.9% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 253.2% in Q3 2021, against a decline of 66.1% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.27 million (Q3 2025), $4.36 million (Q2 2025) and $3.52 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Artelo Biosciences | 85,673.20 | -5.05 Mn | - | 2.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Mar 31, 2024 | 10.35 Mn |
| Dec 31, 2023 | 13.04 Mn |
| Sep 30, 2023 | 15.50 Mn |
| Jun 30, 2023 | 16.88 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 20.42 Mn |
| Sep 30, 2022 | 22.42 Mn |
| Jun 30, 2022 | 24.41 Mn |
| Mar 31, 2022 | 26.70 Mn |
| Nov 30, 2021 | 29.00 Mn |
| Aug 31, 2021 | 12.64 Mn |
| May 31, 2021 | 12.34 Mn |
| Feb 28, 2021 | 13.44 Mn |
API Access
Artelo Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();